These results suggest that the EGFR/TGF-β1/Smad3 biological axis can regulate fibrosis in hypertrophic LF, and EGF may be an important target for the treatment of lumbar spinal stenosis caused by ligamentum flavum hypertrophy. The gene discussed is SMAD3; the disease is lumbar spinal stenosis.